Hongming Chen
陈红敏
Hongming Chen is a U.S. National Academy of Engineering academician who co-founded METiS Pharmaceuticals in 2020 alongside MIT scientists Caida Lai and Wenshou Wang . The company applies AI to precision drug delivery and drug discovery, positioning itself as a global leader in pharmaceutical delivery platforms . In a 2025 interview, Lai described Chen as his partner in the venture, noting that he had joined despite Lai being under thirty with neither money nor experience at the time, drawn instead by Lai's vision and enthusiasm for the field .
AI-generated — may contain errors, please verify.
Hongming ChenPerson
陈红敏
No graph yet
Mentioned in 3 articles
Coverage
The SpaceX of Pharma: Caida Lai's Nanorocket
Only those with fire in their eyes can build rockets.
Monolith砺思资本·5Y News | 5Y Capital Portfolio Company METiS Pharmaceuticals Closes $100 Million Series C Round
Focused on "AI-powered drug delivery."
五源资本·5Y News | METiS Pharmaceuticals Closes Two Consecutive Rounds Raising $150 Million Total
Become an industry innovation leader.
五源资本·


